Top 50 Medical Startup Investors in Austria (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
XISTA Science Ventures
VC Fund
|
8 | Austria, Germany, France | Seed, Pre-Seed, Series A | Biotechnology, Medical, Software | $511k–$20M |
|
xista science ventures
VC Fund
|
5 | Austria, Slovenia | Seed, Pre-Seed, Series A | Biotechnology, Medical, Software | $511k–$20M |
|
Speedinvest
VC Fund
|
5 | United Kingdom, Germany, Austria | Seed, Series A, Pre-Seed | Software, FinTech, Financial Services | $713k–$33M |
|
APEX Ventures
VC Fund
|
4 | Germany, United Kingdom, Austria | Seed, Series A, Pre-Seed | Artificial Intelligence, Software, Health Care | $511k–$22M |
|
SOSV
VC Fund
|
4 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
Cherry Ventures
VC Fund
|
3 | Germany, United Kingdom, United States | Seed, Series A, Series B | Software, Information Technology, Financial Services | $2M–$117M |
|
tecnet equity
VC Fund
|
3 | Austria | Seed, Series A | Software, Biotechnology, Health Care | $400k–$20M |
|
eQventure
VC Fund
|
3 | Austria, Germany, Switzerland | Seed, Series A | Software, Information Technology, Artificial Intelligence | $540k–$6.3M |
|
SquareOne Venture Capital
VC Fund
|
3 | Germany, United States, Poland | Seed, Series A, Series B | Software, Artificial Intelligence, SaaS | $1.4M–$30M |
|
MassMutual Ventures
VC Fund
|
3 | United States, India, Singapore | Series A, Series B, Seed | Software, Financial Services, Information Technology | $2.5M–$50M |
|
VP Venture Partners
VC Fund
|
2 | Austria, Switzerland | Seed | Medical, Health Diagnostics, Internet | $3M–$6.9M |
|
MIG Capital
VC Fund
|
2 | Germany, France, Austria | Series A, Series B | Biotechnology, Health Care, Software | $1.6M–$60M |
|
MMC Ventures
VC Fund
|
2 | United Kingdom, United States, France | Seed, Series A, Series B | Software, Artificial Intelligence, Machine Learning | $1.4M–$54M |
|
Peak Pride
VC Fund
|
2 | Austria, Germany | Seed, Series A, Pre-Seed | Health Care, Medical, Health Diagnostics | $165k–$6.5M |
|
LANA Ventures
VC Fund
|
2 | Austria, Germany | Seed, Pre-Seed | Health Care, Medical, Software | $2.8M–$6.5M |
|
Sven Jungmann
Angel
|
2 | Austria | Seed, Pre-Seed | Medical, Medical Device | |
|
HV Capital
VC Fund
|
2 | Germany, United Kingdom, United States | Series A, Seed, Series B | E-Commerce, Software, Internet | $1.6M–$75M |
|
Daniel Schulte-Hillen
Angel
|
2 | Germany, United Kingdom, Austria | Seed, Pre-Seed, Series A | Blockchain, Sports, Battery | $1.1M–$7.5M |
|
SkyGene
VC Fund
|
2 | Austria | Venture - Series Unknown | Medical, Health Care, Biotechnology | |
|
Rene Schneider
Angel
|
2 | Austria | Seed, Series A | Medical, Analytics, Health Diagnostics | |
|
Ligand Pharmaceuticals
VC Fund
|
2 | United States, Austria, Denmark | Post-IPO Debt, Corporate Round, Post-IPO Equity | Biotechnology, Medical, Health Care | $3M–$90M |
|
aws Gründungsfonds
VC Fund
|
2 | Austria, Germany, United States | Seed, Series A | Software, SaaS, Information Technology | $1.1M–$11M |
|
Johann Hansmann
Angel
|
2 | Austria, United Kingdom, Germany | Seed, Angel, Pre-Seed | Software, Health Care, Fitness | $300k–$3.4M |
|
bmp Ventures
VC Fund
|
2 | Germany, United States, Austria | Seed, Series A | Software, Information Technology, Manufacturing | $30k–$5.9M |
|
Kinled Holding
VC Fund
|
2 | United Kingdom, United States, Switzerland | Seed, Series A | Biotechnology, Health Care, Software | $594k–$40M |
|
West Asia Investment Partners S.a.r.l.
VC Fund
|
1 | Austria | Series A | Medical, Analytics, Health Diagnostics | |
|
Medicus Ltd
VC Fund
|
1 | Austria | Series A | Medical, Analytics, Health Diagnostics | |
|
Nina Capital
VC Fund
|
1 | United States, United Kingdom, Germany | Seed, Pre-Seed, Series A | Health Care, Artificial Intelligence, Software | $529k–$21M |
|
Biopart
VC Fund
|
1 | Austria | Series A | Medical, Analytics, Health Diagnostics | |
|
Novartis Venture Fund
VC Fund
|
1 | United States, Switzerland, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics | $5.1M–$120M |
|
EMBL Ventures
VC Fund
|
1 | Germany, Austria, Ireland | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $3.9M–$70M |
|
Techno Venture Management
VC Fund
|
1 | United States, Germany, United Kingdom | Series B, Series A | Biotechnology, Health Care, Pharmaceutical | $4.7M–$44M |
|
Wellcome Trust
VC Fund
|
1 | United States, United Kingdom, France | Grant, Series C | Biotechnology, Health Care, Medical | $1.6M–$127M |
|
redalpine
VC Fund
|
1 | Germany, Switzerland, United Kingdom | Seed, Series A, Series B | Biotechnology, Health Care, Software | |
|
TBA Network
VC Fund
|
1 | Austria, Italy | Seed | Apps, Medical, mHealth | |
|
GLS Ventures
VC Fund
|
1 | Austria | Series B | Medical, Health Care, Biotechnology | |
|
Santo Holding
VC Fund
|
1 | Germany, Austria | Series B, Series C | Biotechnology, Energy, Medical | |
|
i&i Biotech Fund
VC Fund
|
1 | Czech Republic, India, Spain | Seed, Series A | Biotechnology, Health Care, Medical | |
|
J&T Ventures
VC Fund
|
1 | Czech Republic, United States, Croatia | Seed, Series A | Software, Information Technology, Artificial Intelligence | |
|
Wlanholding GmbH
VC Fund
|
1 | Austria | Seed | Medical, Health Care, Biotechnology | |
|
Rafael Vartian
Angel
|
1 | Austria | Series A | Medical, Analytics, Health Diagnostics | |
|
PONTIS Venture Partners Management
VC Fund
|
1 | Austria, Germany | Series A, Series B, Series C | Software, Manufacturing, Information Technology | $4.9M–$6M |
|
Aescuvest
VC Fund
|
1 | Germany, Israel, Austria | Equity Crowdfunding, Seed | Health Care, Medical, Medical Device | $116k–$2.2M |
|
MMV Europe & Asia-Pacific
VC Fund
|
1 | Singapore, India, United States | Series A, Seed, Series B | Financial Services, FinTech, Health Care | $2.4M–$65M |
|
RoX Health
VC Fund
|
1 | Germany, Austria | Pre-Seed, Seed | Health Care, Health Diagnostics, Apps | |
|
FREE VALLEY HOLDINGS LIMITED
VC Fund
|
1 | Austria | Series A | Medical, Analytics, Health Diagnostics | |
|
Gamma Capital Partners
VC Fund
|
1 | Austria, United States, Germany | Series A, Seed | Software, Manufacturing, Information Technology | $406k–$8M |
|
FCPG Affi
VC Fund
|
1 | Austria | Medical, Biotechnology, Pharmaceutical | ||
|
Ascend Capital Partners
VC Fund
|
1 | Finland, Israel, Austria | Series A, Seed | Health Care, Medical Device, Software | $1.5M–$12M |
|
Boehringer Ingelheim Venture Fund
VC Fund
|
1 | United States, Germany, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $1.8M–$50M |
| Access all 119 investors in Austria Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.
Show more...Investment focus
- Industry: Biotechnology, Medical, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Austria, Germany, France
Investor stats
- Total investments: 45
- Round size: Seed $1.8M–$6.9M; Pre-Seed $511k–$2.3M; Series A $5.7M–$20M
- Lead/follow: 58% lead, 42% follow
Portfolio highlights
- Ribbon Bio — Making The Impossible Possible
- Rivus Batteries — Rivus is a start-up that serves as the commercialization platform for the aqueous organic flow battery technology.
- G.ST Antivirals — G.ST Antivirals focuses on the development of antiviral drugs. G.ST Antivirals utilizes the viral dependency on the host cell metabolism and exploits this to design specific interventions counteracting viral nutrient supply.
We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.
Show more...Investment focus
- Industry: Biotechnology, Medical, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Austria, Slovenia
Investor stats
- Total investments: 22
- Round size: Seed $1.8M–$7.3M; Pre-Seed $511k–$1.5M; Series A $5.7M–$20M
- Lead/follow: 64% lead, 36% follow
Portfolio highlights
- subdron — subdron turns the seabed from a blind spot into a monitored domain.
- infrared.city — Redefine environmental simulations. Our bespoke AI models revolutionise performative design, slashing time, cost, and complexity. Access cutting-edge services effortlessly because innovation should be for everyone
- VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
Speedinvest is a globally active European venture capital firm built on a simple belief: many move more. From six offices across EMEA, our sector-focused investment teams back relentless founders from pre–Seed to Growth with long-term conviction, providing day-one access to our global network of corporate customers, experts, industry leaders, andtop-tier follow-on investors to scale smarter and faster. Building lasting companies like Bitpanda (Austria), Moove (Nigeria), Gigs (U.S.), Tide (UK), ARX Robotics (Germany), Wayflyer (Ireland), GoStudent (Austria), Seqera Labs (Spain), and Cylib (Germany) — together. Big ideas may start with one. But scaling and winning take The Power of More.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, Germany, Austria
Investor stats
- Total investments: 603
- Round size: Seed $1M–$8M; Pre-Seed $713k–$3.8M; Series A $4.1M–$33M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $384M in 2022
Portfolio highlights
- Findery — Find and leave notes anywhere in the world, discover local knowledge, hidden secrets, and exciting stories. Share your travel knowledge, geoblog, or local news!
- Facility — Flexkeeping is a Hotel Operations Platform designed to help teams automate and collaborate like never before.
- Polaron — Material Design. Supercharged with AI.
APEX Ventures is a deep-tech and medical focused venture capital firm, run by founders with complimentary backgrounds driven by the same mission.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United Kingdom, Austria
Investor stats
- Total investments: 53
- Round size: Seed $1.3M–$8M; Pre-Seed $511k–$9.1M; Series A $2.4M–$22M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- GEMESYS — Gemesys creates a chip that functions similarly to the human brain in order to overcome processing constraints and empower AI with the hardware it needs to complete its destiny
- HyperHeat — HyperHeat is building a cutting-edge, all-electric heating solution designed to reach temperatures of up to 2,000°C. Using renewable electricity HyperHeat is providing an efficient alternative to fossil fuel combustion. With an efficiency rate of up to 98%, HyperHeat is ideal for retrofitting industrial processes, enabling significant CO2reductions across industries like steel, cement, and chemicals. The scalable technology offers a cost-efficient approach to decarbonizing thermal processes, with a potential to reduce global CO2 emissions by over 4.5 gigatons annually.
- TriLite Technologies — The world's smallest projection displays from TriLite take laser beam scanning technology to the next level, for augmented vision as light as the eyewear of today.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Cherry Ventures is an early-stage venture capital firm led by a team of entrepreneurs with experience building fast-scaling companies such as Zalando and Spotify. The firm backs Europe's boldest founders, usually as their first institutional investor, and supports them in everything from their go-to-market strategy and the scaling of theirbusinesses. Cherry Ventures has previously invested in the seed stage of over 50 companies across Europe, including FlixBus, Auto1 Group, Infarm, Rows, Forto, and TourRadar. Cherry Ventures is based in Berlin and invests across Europe with operations in London, Paris, and Stockholm.
Show more...Investment focus
- Industry: Software, Information Technology, Financial Services
- Stage:Seed, Series A, Series B
- Geography: Germany, United Kingdom, United States
Investor stats
- Total investments: 287
- Round size: Seed $2M–$14M; Series A $7.2M–$44M; Series B $14M–$117M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $340M in 2022
Portfolio highlights
- Moss — Moss is a technology-based payment and credit card platform that enables companies to optimize their finances. Thanks to a dynamic and up to 10x higher limit, our corporate credit card can handle even the highest spend. With virtual and physical credit cards, the entire team can spend easily and securely. Individual spending limits and real-timedata per card, merchant or team keep costs under control. The Moss app makes it easy to digitize receipts, including cost center and VAT assignment. At the end of the month, all data and documents can be exported to any accounting software.
- Bits Technology — Bits Technology connects data sources & orchestrates workflows for financial tech services.
- Black Forest Labs — Official Account: https://t.co/iF047jr0Yg @bfl_ai
tecnet equity is an Austrian venture capital fund investing in innovative high-tech companies with potential for significant growth.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A
- Geography: Austria
Investor stats
- Total investments: 71
- Round size: Seed $400k–$2.5M; Series A $583k–$20M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — last raise in 2009
Portfolio highlights
- PROPCORN AI — At PROPCORN, our goal is to harness the power of AI to automatically unlock the full real estate building potential of our customers, enabling them to make faster and more accurate decisions in real-time.
- Ribbon Bio — Making The Impossible Possible
- Greenwood-Power — Greenwood-Power is the leading innovator for non-conventional transformers. Let's talk about your individual requirements - CONTACT US TODAY!
Entrepreneurs for Entrepreneurs
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A
- Geography: Austria, Germany, Switzerland
Investor stats
- Total investments: 60
- Round size: Seed $540k–$1.2M; Series A $768k–$6.3M
- Lead/follow: 77% lead, 23% follow
Portfolio highlights
- Diamens — Diamens is a company focused on femtech that develops a non-invasive menstrual blood-based molecular diagnostic to detect women-specific diseases like endometriosis.
- Respory — Respory provides real-time people-tracking using proprietary radar sensors, all without capturing personal data. Our scalable sensor network, powered by AI-driven algorithms, delivers precise customer journey insights, critical for in-store performance in retail.
- 2nd Cycle — 2nd Cycle creating a cost-effective, fully automated, and scalable solution for modules for a second life cycle.
We invest in B2B tech entrepreneurs who are obsessed with solving complex problems in huge markets at pre-seed and seed stage
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A, Series B
- Geography: Germany, United States, Poland
Investor stats
- Total investments: 65
- Round size: Seed $1.4M–$7.4M; Series A $4.2M–$20M; Series B $5M–$30M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- Ultralytics — Simpler. Smarter. Further.
- Flinn — We are driven to impact the health of millions of people around the globe by enabling medical companies to launch and operate products more efficiently. To make this vision come true, we established a customer-centric, experimentation-driven product development approach.
- Graph Therapeutics — Graph Therapeutics - precision immunology
MMV is a multistage, global venture capital firm investing in enterprise software, cybersecurity, financial technology, and digital health companies. We help accelerate the growth of the companies we partner with by providing capital, connections and advice.
Show more...Investment focus
- Industry: Software, Financial Services, Information Technology
- Stage:Series A, Series B, Seed
- Geography: United States, India, Singapore
Investor stats
- Total investments: 154
- Round size: Seed $2.5M–$9.3M; Series A $5M–$23M; Series B $7M–$50M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — raised $100M in 2022
Portfolio highlights
- Versana — Centralized, real-time digital agent data unlocks end-to-end solutions across the $8T broadly syndicated loan and private credit markets.
- EduFund — EduFund is India's leading education finance platform, helping parents plan, save, and pay for their child's higher education, in India or abroad. Co-founded in 2020 by Eela Dubey and Arindam Sengupta, EduFund was built on a simple conviction: most Indian families focus intensely on academic preparation for college and almost entirelyignore the financial side until it's too late. Eela Dubey, Co-founder and CEO, is a NYU graduate with a background in hedge funds on Wall Street. Arindam Sengupta, Co-founder, is a Princeton University alumnus with experience at Citadel and Reliance Capital. Together, they built EduFund to close the gap between being academically ready and financially ready for higher education. The platform offers a full suite of education finance tools, including mutual fund SIPs, fixed deposits, digital gold, and term insurance, alongside education loans, scholarship discovery, and end-to-end admissions support. Its AI-powered college cost calculator, Taara, gives parents inflation-adjusted cost estimates across 3,000+ colleges in 19+ countries in seconds, factoring in tuition, living costs, and currency risk. EduFund started out as a B2C app for consumers. EduFund's B2B platform, Vittam, serves to scale the same mission through India's MFD ecosystem, enabling wealth distributors to offer their clients a broader suite of financial products, from education loans and GIFT City funds to EB-5 global investment products and international health insurance. EduFund has served 250,000+ families and built a partner network of 40+ asset management firms and 15+ lending institutions, along with over 300 MFDs and IFA's through it's B2B vertical, Vittam. EduFund has raised $12 million in total funding, including a $6 million Series A led by Cercano Management and MassMutual Ventures. The company is also supported by angel investors.
- One — The Digital Payments Platform Built for the Insurance Industry. This platform offers customers the ability to make digital premium and claim payments.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!VP Venture Partners is a venture capital firm invests in healthcare companies.
Show more...Investment focus
- Industry: Medical, Health Diagnostics, Internet
- Stage:Seed
- Geography: Austria, Switzerland
Investor stats
- Total investments: 7
- Round size: Seed $3M–$6.9M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Diamens — Diamens is a company focused on femtech that develops a non-invasive menstrual blood-based molecular diagnostic to detect women-specific diseases like endometriosis.
- Moonlight AI — Moonlight AI was created to democratize the access to genomic information that is essential for therapy decision making in the era of personalized medicine.
- CollimateHealth — CollimateHealth is creating a clinically scalable microbeam radiation technology that will revolutionize the treatment of cancer.
MIG Capital is one of the leading German VC Investors. We invest in European Deep Tech and Life Sciences from early to late stage (Seed, Series A, and beyond). We use investments to shape a better tomorrow, today. Our team currently manages 17 MIG public venture capital funds regulated by BaFin, the German financial markets authority. These fundsoperate with more than EUR 1.2 billion capital committed by >60,000 private investors across Germany and Austria.Today, our portfolio consists of 30 companies.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series A, Series B
- Geography: Germany, France, Austria
Investor stats
- Total investments: 97
- Round size: Series A $2.2M–$40M; Series B $1.6M–$60M
- Lead/follow: 44% lead, 56% follow
- Last fund: May invest from a new fund soon — raised $70M in 2014
Portfolio highlights
- NcodiN — The High Performance Computing (HPC) and ArtificiaI Intelligence (AI) era requires unprecedented computing capabilities. With this in view, industry is heading towards zettascale supercomputers, based on >100k processing units. Chiplets-based disaggregated processors and memory-centric computing architectures are taking over and require an ever more intensive communication between dies. Thus, today interconnect bottleneck is the main
- GlassPoint Solar — GlassPoint provides solar steam generators to the oil and gas industry for applications such as Enhanced Oil Recovery. It replaces gas-fired steam generation with solar, GlassPoint can reduce EOR gas consumption by up to 80 percent. The company was founded in 2008 and headquartered in Fremont, California.
- Zadient Technologies — Zadient produces semiconductor manufacturing materials that are critical for the entire silicon carbide (SiC) value chain
MMC is a venture capital fund investing in early stage, high-growth UK companies. Investing in technology companies at Seed and Series A.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 244
- Round size: Seed $1.4M–$9.8M; Series A $2.4M–$19M; Series B $6M–$54M
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — raised $124M in 2019
Portfolio highlights
- Gardin — We believe in a world in which everyone has the right to access high quality, nutritious food that is good for you and for our planet. Our environmental issues are real, something, somewhere needs to change. Gardin promises to create the step-change required by deploying its technology.
- ABEX — Algorithmic Best Execution for digital assets driven by an ultra low latency, high frequency, agency trading engine and enhanced by deep quantitative research.
- Stanhope AI — Stanhope AI is a deep-tech startup based in London with a strong background in neuroscience, robotics and fintech. We are bringing Active Inference to market as a novel framework for autonomous decision-making. To contend with the challenges of contemporary AIs, our distinct approach aims to offer
Multi family office investing in proptech, digital health & sustainability
Show more...Investment focus
- Industry: Health Care, Medical, Health Diagnostics
- Stage:Seed, Series A, Pre-Seed
- Geography: Austria, Germany
Investor stats
- Total investments: 10
- Round size: Seed $165k–$658k; Series A $2.4M–$6.5M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Greenpass — Greenpass is an all-in-one SaaS for climate-resilient urban planning & architecture platform that enables livable cities.
- Kranus Health — Kranus Health is a global provider for Men‘s Health Prescription Digital Therapeutics (PDTs). Our therapies make millions of men live a better and longer life and enable doctors to treat their patients more efficiently.
- HelloBello — HelloBello offers freshly cooked and cooled delivered human-grade food tailored to each dog’s nutritional needs. HelloBello is a PetTech company with a strong focus on the German speaking markets (for now). HelloBello’s personalized meals are free of any by-products and are portioned, packaged, and delivered directly to your door. By working with aspecialized veterinarian, HelloBello is able to derive each dog’s exact nutritional needs based on a proprietary algorithm. The recipes are made of natural sources like millet and seaweed, instead of heavy use of supplements, which makes it easier for the dog to absorb and get true nutritional benefits.Our credo in German is " ... Frisch. Individuell. Geliefert. - Frischfutter ist einfach besser ..."
LANA Ventures is a venture capital firm.
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Seed, Pre-Seed
- Geography: Austria, Germany
Investor stats
- Total investments: 4
- Round size: Seed $2.8M–$6.5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- XUND — Answer the most important health questions with AI-powered technology from XUND. Medically certified and CE marked.
- UniteLabs — UniteLabs provides the foundational operating system for AI-driven lab automation in life science. It accelerates scientific discovery by closing the loop with a unified data and automation infrastructure, seamless integration, and intelligent control. Our platform empowers ambitious biotech companies, big pharma, integrators, and hardware vendorsby offering bidirectional connectors for diverse lab equipment, a scalable cloud platform with an open API, and a powerful workflow engine with an integrated compute environment. This allows for the creation of sophisticated, modular workflows, and enables rapid automation development through our Lab-as-Code environment, featuring a dynamic Python SDK and application-specific libraries.
- Aitiologic — A precision medicine startup providing multi-modal liquid biopsy solutions for early disease detection and targeted therapy.
As a physician, I cherished every life touched, every suffering eased; yet I yearned for more - a greater, scalable social impact. I dreamt of a world where my own reach was not limited by the confines of time or distance, where every doctor could harness the power of technology to multiply their healing touch. Today, this dream takes shape throughour breath diagnostics company, where we strive to equip hundreds of thousands of doctors worldwide with our pioneering technology, thereby transforming patient care. We are crafting a future where technology and compassion converge, redefining the boundaries of what we, as physicians, can achieve for our patients.
Show more...Investment focus
- Industry: Medical, Medical Device
- Stage:Seed, Pre-Seed
- Geography: Austria
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Flinn — We are driven to impact the health of millions of people around the globe by enabling medical companies to launch and operate products more efficiently. To make this vision come true, we established a customer-centric, experimentation-driven product development approach.
HV Capital is one of the leading early-stage and growth investors in Europe. With nine fund generations in 23 years and €2.8 bn in managed assets, HV Capital is one of the continent's most active investors. The investment team has many years of experience in identifying European startups with great potential for success. In addition tointernational success stories like Zalando, Delivery Hero, Sumup, and Depop, innovation leaders such as Enpal, Flixbus, Sennder, and Isar Aerospace are also part of the portfolio. HV Capital has invested in around 225 internet and technology companies, supporting startups with ticket sizes ranging from €0.5 to €60m. It is one of Europe's few venture capital firms that can finance startups through all growth phases. HV Capital has a team of more than 40 investment and operations professionals who provide a variety of perspectives and expertise across the venture capital landscape.
Show more...Investment focus
- Industry: E-Commerce, Software, Internet
- Stage:Series A, Seed, Series B
- Geography: Germany, United Kingdom, United States
Investor stats
- Total investments: 467
- Round size: Seed $1.6M–$12M; Series A $3.3M–$35M; Series B $7.7M–$75M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $834M in 2023
Portfolio highlights
- Exein — Exein develops embedded cybersecurity solutions designed to secure Internet of Things (IoT) and connected devices. The company provides a platform that integrates security directly into the firmware of embedded systems, enabling real-time threat detection, monitoring, and response. Exein’s technology focuses on runtime protection and behavioranalysis at the edge, helping manufacturers secure devices without requiring major hardware changes or external software agents. Its solution is compatible with widely used real-time operating systems (RTOS) and Linux-based environments, allowing for flexible integration across different devices. The company also offers tools for vulnerability assessment and threat intelligence tailored for firmware-level defense. Exein supports developers with APIs and SDKs to incorporate security features during the product development phase. Through its platform, the company addresses growing security risks in critical sectors such as automotive, industrial automation, and consumer electronics.
- Fleek — Fleek is a B2B Wholesale Marketplace for second-hand fashion. Our buyers are vintage stores and online resellers; our suppliers are used clothing wholesalers, rag-houses, and donation centres.
- Ore Energy — Ore Energy is creating a new generation, cost effective, long-duration energy storage solution which will enable a decarbonized energy future by utilizing some of the most readily available materials
Founding GP @SDAC Ventures. Formerly product @N26 and @Taxfix, strategy @HEC, org theory @ZeppelinUni and Ethereum @ETHBerlin.
Show more...Investment focus
- Industry: Blockchain, Sports, Battery
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, United Kingdom, Austria
Investor stats
- Total investments: 9
- Round size: Seed $2M–$7.5M; Pre-Seed $1.1M–$3.5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Tromero — Tromero - cost effective Machine Learning Training & Hosting
- Cardino — Cardino - Verkaufen Sie Ihr E-Auto digital zum besten Preis. Entdecken Sie die einfache und bequeme Art, Ihr Elektroauto online zu verkaufen.
- Flinn — We are driven to impact the health of millions of people around the globe by enabling medical companies to launch and operate products more efficiently. To make this vision come true, we established a customer-centric, experimentation-driven product development approach.
SkyGene is a venture capital firm. The firm intends to invest in biotech firms.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Venture - Series Unknown
- Geography: Austria
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
Rene Schneider
Show more...Investment focus
- Industry: Medical, Analytics, Health Diagnostics
- Stage:Seed, Series A
- Geography: Austria
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that helps people understand their health by explaining their medical reports and health data to them in a personalized, easy-to-understand, and visual way.Through its consumer apps and enterprise software, Medicus is focused on bringing meaning to data, by helping patients and users understand theirhealth, and augmenting the roles of doctors, midwives, and other healthcare providers through innovative data visualization, patient communication, and remote monitoring tools.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!A genetic medicines company developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Post-IPO Debt, Corporate Round, Post-IPO Equity
- Geography: United States, Austria, Denmark
Investor stats
- Total investments: 19
- Round size: Post-IPO Debt $15M–$85M; Corporate Round $3M–$10M; Post-IPO Equity $15M–$90M
- Lead/follow: 58% lead, 42% follow
Portfolio highlights
- Agenus — Activating the Power of the Immune System to Defeat Cancer
- Zerion Pharma — Zerion Pharma is a pharmaceutical company that aims to transform the pharmaceutical landscape with a new formulation technology. The company is focused on improving existing drugs by building an internal pipeline to solve the most challenging drug solubility problems that pharmaceutical companies face. Zerion Pharma was founded in 2019 and isbased in Birkerød, Denmark.
- Castle Creek Biosciences — Dedicated to making life better for people suffering from rare diseases with few or no treatment options
aws Gründerfonds is Austria's 70m venture capital fund. We invest as co-investor in Austrian high-growth start-ups in their later seed and (pre-)series-A stages.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Series A
- Geography: Austria, Germany, United States
Investor stats
- Total investments: 91
- Round size: Seed $1.3M–$5.2M; Series A $1.1M–$11M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- refinq — Our platform helps companies transform climate and biodiversity risks into opportunities to reduce costs, future-proof operations, and stay competitive.
- vitrealab — Enlighten. Your perspective. Light Engines for AR glasses.
- Invisible-Light Labs — Invisible Light Labs uses Fourier transform infrared (FTIR) spectroscopy and nanoelectromechanical sensing technologies to enable chemical analysis of materials and nanomaterials that are available in minuscule amounts in a variety of industries, from environmental monitoring to pharmaceuticals.
Dr. Johann ‘Hansi’ Hansmann was born in Austria and studied economics in Vienna. He spent the major part of his professional life working as an executive in the pharmaceutical industry in Austria, Germany, UK and Spain. He gathered several years of entrepreneurial experience running successfully his own pharmaceutical company in Spain afterconducting a management buy-out of a big pharmaceutical plant, making an exit in 2003. Since this time he is active as investor and business angel. He currently holds investments with a geographical focus on Austria, Germany, UK and Spain both internet and in the health industry. He led Runtastic, shpock, mysugr and just recently durchblicker and Busuu to extraordinary exits. He was president of the ‘Austrian Angels Investors Association’ until 2021, was awarded 'Best European Early Stage Investor' in 2016 by eban.org and is now based in Vienna and tries to find spare time to ride his mountain bike.
Show more...Investment focus
- Industry: Software, Health Care, Fitness
- Stage:Seed, Angel, Pre-Seed
- Geography: Austria, United Kingdom, Germany
Investor stats
- Total investments: 73
- Round size: Seed $300k–$3.4M; Angel $350k–$630k; Pre-Seed $439k–$2.8M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- fynk — Create, edit, negotiate and sign contracts quickly with fynk. Give your team back valuable time. Test it now for free!
- Newsrooms.ai — Newsrooms.ai is an AI-powered content production and management platform that enables businesses and news organizations to automate their whole content pipeline—from research and content generation to publishing across many digital channels.
- Donnerstag.ai — We customize reconciliation automation to your ecosystem, so every line item is reconciled in real time.
bmp Ventures is an innovative Venture Capital Company from Berlin. Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Seed, Series A
- Geography: Germany, United States, Austria
Investor stats
- Total investments: 120
- Round size: Seed $165k–$3.4M; Series A $30k–$5.9M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Sedivention — Fight obesity within 20 minutes - fast, effective, long-term. A new weight-loss therapy for the treatment of obesity. Just a view minutes will change your life.
- Solar Materials — Solar Materials primarily engages in the development of technologies for the sustainable and economical recycling of solar modules.
- Litherm Technologies — Fully electric calcination as a pathway to zero-emission lime and cement production.
Kinled was founded in 1980 to retain the investment assets of the Aisher family.In 1990, the investment focus shifted to a portfolio of early stage investments applying Kinled’s company development experience alongside the endurance and passion of family owned investments together with the strategic focus of venture capitalists.Since then,Kinled has taken 8 companies to public markets and many more to successful trade sales at significant multiples.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Switzerland
Investor stats
- Total investments: 139
- Round size: Seed $594k–$14M; Series A $1.7M–$40M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Esper — Esper is the first cloud-based platform to help governments proactively manage public policy with better data and transparency.
- Varda — Expanding the economic bounds of humankind with the world's first orbital manufacturing & reentry platform.
- TAG Therapeutics — TAG Therapeutics develops precision medicine approaches for telomere pathologies and aging-related diseases, such as Idiopathic Pulmonary Fibrosis and Short Telomere Syndromes
Investment Company
Show more...Investment focus
- Industry: Medical, Analytics, Health Diagnostics
- Stage:Series A
- Geography: Austria
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that helps people understand their health by explaining their medical reports and health data to them in a personalized, easy-to-understand, and visual way.Through its consumer apps and enterprise software, Medicus is focused on bringing meaning to data, by helping patients and users understand theirhealth, and augmenting the roles of doctors, midwives, and other healthcare providers through innovative data visualization, patient communication, and remote monitoring tools.
Investor
Show more...Investment focus
- Industry: Medical, Analytics, Health Diagnostics
- Stage:Series A
- Geography: Austria
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that helps people understand their health by explaining their medical reports and health data to them in a personalized, easy-to-understand, and visual way.Through its consumer apps and enterprise software, Medicus is focused on bringing meaning to data, by helping patients and users understand theirhealth, and augmenting the roles of doctors, midwives, and other healthcare providers through innovative data visualization, patient communication, and remote monitoring tools.
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 95
- Round size: Seed $2M–$6.3M; Pre-Seed $529k–$2.4M; Series A $5M–$21M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Biobase — Biobase is the agentic system for clinical data, closing the gap between clinical data and outcomes.
- Ladder Health — Ladder Health offers virtual pediatric therapy and support for early childhood developmental delays, including speech and physical therapy.
- Woodway Assurance — Woodway Assurance provides EviData, an AI-driven software for automated privacy assurance on de-identified and synthetic datasets.
Biopart
Show more...Investment focus
- Industry: Medical, Analytics, Health Diagnostics
- Stage:Series A
- Geography: Austria
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that helps people understand their health by explaining their medical reports and health data to them in a personalized, easy-to-understand, and visual way.Through its consumer apps and enterprise software, Medicus is focused on bringing meaning to data, by helping patients and users understand theirhealth, and augmenting the roles of doctors, midwives, and other healthcare providers through innovative data visualization, patient communication, and remote monitoring tools.
Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Series C
- Geography: United States, Switzerland, United Kingdom
Investor stats
- Total investments: 219
- Round size: Series A $5.1M–$81M; Series B $11M–$120M; Series C $9M–$75M
- Lead/follow: 26% lead, 74% follow
- Last fund: May invest from a new fund soon — raised $200M in 2009
Portfolio highlights
- Bionano Genomics — Discover how Bionano is striving to elevate health and wellness for all through optical genome mapping (OGM) solutions that transform the way the world sees the genome.
- Protego Biopharma — Protego Biopharma develops therapeutics based on the clear human genetic link, excellent human safety profile, proof-of-principle efficacy. The company was founded in 2011 and is headquartered in San Diego, California.
- Twentyeight-Seven Therapeutics — Maxslot88 merupakan link situs slot gacor gampang menang jackpot maxwin hari ini sebagai daftar apk slot88 terpercaya dengan server thailand resmi, memberikan pengalaman bermain slot online yang aman dan menghibur bagi semua klien.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!EMBL Ventures invest throughout Europe with the aim to build companies that create significant commercial opportunities based on new therapeutic treatment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: Germany, Austria, Ireland
Investor stats
- Total investments: 11
- Round size: Series A $3.9M–$15M; Series B $21M–$70M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- Arsanis — Arsanis is a clinical-stage biopharmaceutical company focused on applying monoclonal antibody (mAb) immunotherapies to address serious infectious diseases. A deep understanding of the pathogenesis of infection, paired with access to some of the most advanced mAb discovery techniques and platforms available today, has positioned Arsanis to build andadvance a pipeline of novel mAbs with multiple mechanisms of action and high potency against their intended targets.The company’s lead clinical program, ASN100, is aimed at serious Staphylococcus aureus infections and is being evaluated in Phase 2 clinical trial for the prevention of S. aureus pneumonia in high-risk, mechanically ventilated patients. In addition to ASN100, its preclinical pipeline is comprised of mAbs targeting multiple serious bacterial and viral pathogens, including respiratory syncytial virus.Arsanis is a U.S. company headquartered in Waltham, Massachusetts, with European research and preclinical development operations headquartered in Vienna, Austria (Arsanis Biosciences GmbH).
- Topas Therapeutics — Topas Therapeutics GmbH is a private Hamburg, Germany-based biotechnology company focused on developing products to address areas of major unmet need, including autoimmune diseases, allergies and anti-drug antibodies. The Topas Particle Conjugates technology platform induces antigen-specific immune tolerance by harnessing the liver’s naturalimmunology capabilities. The Company has several proprietary programs; lead product candidate TPM203 has recently entered clinical testing for pemphigus vulgaris, an orphan disease. Other programs are in anti-drug antibodies, celiac disease, Type 1 diabetes, as well as a multiple sclerosis program that is available for partnering.Topas has a research and option agreement with Eli Lilly and Company focused on antigen-specific tolerance induction and a multi-year agreement with Boehringer Ingelheim to collaborate in the field of anti-drug antibodies.Topas’ investors include: Epidarex Capital, Gimv, EMBL Ventures, Evotec and Boehringer Ingelheim Venture Fund.
- Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
Techno Venture Management is a venture capital and private equity firm focused on healthcare industry.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series B, Series A
- Geography: United States, Germany, United Kingdom
Investor stats
- Total investments: 99
- Round size: Series A $4.7M–$22M; Series B $5.2M–$44M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Streaming21 — Streaming21 is a solution provider of seamless on-demand and IP broadcasting service platform for connected digital home.
- Helomics — Helomics® is a comprehensive personalized healthcare company, bringing the next generation of diagnostics to the oncology field. Helomics is dedicated to improving patient outcomes by providing a personalized comprehensive tumor profile utilizing a proprietary set of laboratory platforms that leverage both tissue-based live and fixed cellular basedanalysis allowing physicians to characterize malignant tumors on a personalized basis. Helomics’ novel molecular and cellular markers and bioinformatics services support treatment decisions by providing vital information based on the specific biological processes of each individual’s cancer.
- Precision Therapeutics — Precision Therapeutics is a pharmaceutical research and development business that develops personalized cancer treatments for patients.
Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science. It was founded in 1936 and headquartered in London, England.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Grant, Series C
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 125
- Round size: Grant $1.6M–$10M; Series C $10M–$127M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — raised $319M in 2018
Portfolio highlights
- Lario Therapeutics — Lario Therapeutics are developing first-in-class disease modifying treatments for severe neurological disorders. Precision Neuroscience Today.
- Wysa — Use Wysa to vent or just talk through negative thoughts and emotions. Let it help you cope with pandemic anxiety and lockdowns. It is anonymous, safe and free.
- Ineffable Intelligence — Making first contact with superintelligence.
redalpine is a thesis-driven vc with deep expertise in software and science. since 2006. we believe in the power of big ideas and in empowering game changers. we don't just invest, we co-create a better tomorrow. together with you.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A, Series B
- Geography: Germany, Switzerland, United Kingdom
Investor stats
- Total investments: 167
- Lead/follow: no public data
Portfolio highlights
- Inkitt — Publish stories online, join our author subscription program, and read books online for free. Join the Inkitt community for writers and readers today.
- Donut — Donut helps people discover new ways to build wealth, by providing the easiest and most trusted way to save & earn high yield with DeFi. Donut was founded in 2018 and is dual headquartered in Los Angeles and Berlin.
- Umiami — Umiami Technologies is a leader in plant-based meat. Our proprietary technology allows us to create clean-label and incredibly tasty foods.
TBA Network provides risk capital, entrepreneurial expertise, and valuable network support to ambitious founders. TBA objective is to support innovative ideas and contribute to the global expansion of early-stage startups, laying the groundwork for future entrepreneurs.
Show more...Investment focus
- Industry: Apps, Medical, mHealth
- Stage:Seed
- Geography: Austria, Italy
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- XUND — Answer the most important health questions with AI-powered technology from XUND. Medically certified and CE marked.
- Tree.ly — Tree.ly does climate protection through the projects in European forests through its SaaS platform and hyperlocal CO2-credits.
- ALLSIDES — Covision Media specializes in creating high-quality, relightable 3D models using their industrial 3D scanners. These scanners capture detailed surface information and PBR textures, and are designed for easy integration into virtual environments.
GLS Ventures
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series B
- Geography: Austria
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Nabriva Therapeutics — MPOMM Adalah link resmi berlisensi agen mpo slot paling gacor hari ini dengan pilihan bermain di server slot anti rungkat terjamin kemenangan jackpot maxwin menang berapapun akan di bayar lunas
Santo Holding is a Zurich-based investment firm funding biotechnology, pharmaceutical, life sciences, and healthcare companies.
Show more...Investment focus
- Industry: Biotechnology, Energy, Medical
- Stage:Series B, Series C
- Geography: Germany, Austria
Investor stats
- Total investments: 6
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
- SuppreMol — SuppreMol is a privately held biotechnology company that pioneers a novel approach for the treatment of autoimmune diseases which could lead to the cure of these disorders instead of merely treating their symptoms.
- Efficient Energy — Efficient Energy GmbH is an innovative manufacturer and system supplier of environmentally friendly refrigeration technology, based in Feldkirchen near Munich, Germany. The company developed the Bluezero-technology, which uses water as a refrigerant and and thereby entirely avoids fluorinated refrigerants (HFCs). Efficient Energy helps itscustomers overcome the increasing regulatory challenges of refrigeration technology, and offers them long-term, sustainable solutions with its eChiller model range. The eChiller chilled water units are ideally suited for process cooling, machine cooling and the cooling of technical equipment and data centres and provide cooling capacities from 35 kW to 120 kW, depending on the model. With its outstanding cost efficiency and low CO2 footprint, companies benefit on many fronts. The pioneering technology has also been noticed by politics and the media, and has received multiple awards for the eChiller. These include among others the European Business Award for the Environment 2018/2019 from the European Comission and the Red Herring Europe Top 100 in 2020.
We are i&i Biotech Fund, partners of outstanding founders on their path to global success. We invest in innovative early stage Life Sciences startups.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: Czech Republic, India, Spain
Investor stats
- Total investments: 10
- Lead/follow: no public data
Portfolio highlights
- Antiverse — Designing biologics for 100 challenging targets
- Captain T Cell — Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients. The company identifies novel high-efficiency TCRs for the development of T cell immunotherapies. It focuses on CMC- and preclinical development for their lead candidates.
- Casinvent Pharma — Casinvent Pharma develops new therapeutic options for the treatment of selected malignancies.
J&T Ventures is an early-stage Prague-based Venture Capital fund, which invests in promising startups from the CEE and SEE region. Our strategy is industry agnostic, but we primarily focus on companies in the seed stage with proven product market fit. Our average ticket size is between EUR 0.5m - EUR 2.5m.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A
- Geography: Czech Republic, United States, Croatia
Investor stats
- Total investments: 52
- Lead/follow: no public data
Portfolio highlights
- XUND — Answer the most important health questions with AI-powered technology from XUND. Medically certified and CE marked.
- Wultra — Wultra helps the leading banks and fintech companies to secure their digital systems and bring trust to the customer journeys. Our security-related software technologies cover the whole digital banking application stack, be it on the web or mobile platforms.
- Grid.online — Grid.online is building transportation infrastructure as a service that will unlock the huge free transportation capacity of cities and allow it to be shared efficiently.
Led by Werner Lanthaler, Wlanholding invests in life sciences and sustainability, advancing innovation and growth in cutting-edge technologies.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed
- Geography: Austria
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- aTension.life — aTension.life is a company focused on advancing the diagnosis and treatment of hypertension through precision medicine. It employs cutting-edge mass spectrometry technology to identify the underlying causes of uncontrolled hypertension using a single blood sample. aTension.life aims to provide personalized diagnostic solutions that enhance patientcare and support laboratories with accurate and reliable tools. The company's mission is to improve the quality of life for hypertensive patients by making advanced diagnostics widely accessible and enabling more effective, individualized therapies.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Rafael Vartian
Show more...Investment focus
- Industry: Medical, Analytics, Health Diagnostics
- Stage:Series A
- Geography: Austria
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that helps people understand their health by explaining their medical reports and health data to them in a personalized, easy-to-understand, and visual way.Through its consumer apps and enterprise software, Medicus is focused on bringing meaning to data, by helping patients and users understand theirhealth, and augmenting the roles of doctors, midwives, and other healthcare providers through innovative data visualization, patient communication, and remote monitoring tools.
PONTIS Capital manages two funds with total commitments of more than EUR 60 million, and is actively investing out of its second fund, PONTIS Growth Capital II (“PGC II”). The focus of PGC II is to invest in small and medium-sized growth companies with Established technology or other competitive advantage Existing proof-of-market in marketswith growth potential,Scalable business models, andHeadquarters in the DACH region (Germany, Austria, Switzerland)
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Series A, Series B, Series C
- Geography: Austria, Germany
Investor stats
- Total investments: 7
- Round size: Series A $4.9M–$6M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- evidanza — evidanza GmbH is a software provider of business intelligence solutions for reporting, planification, OLAP-analysis, risk management, costs calculations, IFRS- and USGAAP-reporting. The company is headquartered in Salching, Germany.
- SensorDynamics — SensorDynamics was a European semiconductor and MEMS company specialized in developing and manufacturing high-volume micro- and wireless semiconductor sensor products for applications in automotive, industry and high-end consumer sectors. The company was acquired by Maxim Integrated in 2011 for $164 million. SensorDynamics developed and producedcustom-made designs and standard components for use in vehicle stabilization, occupant protection, navigation systems, keyless go systems and autonomous energy generators for wireless and battery free controllers for industrial, automotive and high-end consumer application.[5] With its headquarters in Graz, Austria, SensorDynamics had offices in Italy and Germany and a worldwide sales and distribution network. The company employed about 130 people in 2011.
- GAT Microencapsulation — OMPONG188 adalah situs resmi yang menghadirkan link akses slot gacor bebas IP, anti nawala dan loading cepat jika diakses diperangkat manapun dan dimanapun anda berada. Daftar melalui link resmi OMPONG188 dengan akses cepat, aman dan terpercaya.
Aescuvest’s mission is to facilitate and enable impactful investments into medical breakthrough innovation to disrupt and improve healthcare delivery models, products, and services. Aescuvest enables its investors to build their very individual portfolio of healthcare start-ups - according to their personal investment focus. A cooperation with EITHealth, and a growing network of partnerships across Europe, allow Aescuvest to source and evaluate the most promising healthcare investment opportunities, structure their financing rounds, and enable healthcare technology-driven investors, such as Business Angels, HNWIs, Family Offices, and Corporate Investors, to participate in healthcare investment opportunities by direct investments via SPV structures. The Investment Committee, composed of Aescuvest’s very own investment team and members of tthe Advisory Board of Aescuvest, both deeply rooted in the healthcare industry and with proven track records, have developed a strong and over the last years well tested, pre-screening and due diligence process, to identify and select healthcare start-ups. Aescuvest’’s Management (circle of General Partners) put their ‘skin’ into each investment by committing capital to each company prior introduction to the wider Aescuvest investor base. The combination of innovative ways for equity capital provision, with healthcare industry and investment expertise, provides the Aescuvest portfolio companies a unique platform to develop their business solution, accelerate their path towards commercialization, and lower market access barriers.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Equity Crowdfunding, Seed
- Geography: Germany, Israel, Austria
Investor stats
- Total investments: 26
- Round size: Seed $1.1M–$2.2M; Equity Crowdfunding $116k–$666k
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- XO Life — XO Life is to build the largest real-world evidence platform for patient insights for all medications and therapies. Together with one of Europe's leading research institutes for patient-centered research, the PROMIS Institute Germany of the Charité, and various pharmaceutical manufacturers, patient experiences are to be recorded in astandardized and systematic manner across a wide range of diseases. Patients are to be enabled to record their therapy course and outcome independently as well as scientifically validated so that these patient insights from real treatment practice can be used in the life science industry and by medical professions.
- piur imaging — PIUR´s tomographic ultrasound solutions turn any standard ultrasound system into a tomographic 3D imaging device, bridging the gap between 2D ultrasound and regular tomographic imaging modalities. With any conventional 2D ultrasound transducer, high-resolution tomographic images can be generated and stored as quantifiable volumes, enabling true AIpost-processing for efficient diagnostics. Current focus is on thyroid imaging where AI algorithms allow doctors a fast and objective analysis and classification of thyroid nodules.
- Neteera — Neteera's FDA-clear contactless RPM platform transforms patient care by accurately monitoring heart rate, respiratory rate, and behavioral parameters.
MMV is a multistage, global venture capital firm investing in enterprise software, cybersecurity, financial technology, and digital health companies. We help accelerate the growth of the companies we partner with by providing capital, connections and advice.
Show more...Investment focus
- Industry: Financial Services, FinTech, Health Care
- Stage:Series A, Seed, Series B
- Geography: Singapore, India, United States
Investor stats
- Total investments: 33
- Round size: Seed $2.4M–$7.5M; Series A $4M–$15M; Series B $20M–$65M
- Lead/follow: 58% lead, 42% follow
- Last fund: May invest from a new fund soon — raised $100M in 2020
Portfolio highlights
- Sikoia — Streamline your decision-making with centralized customer data, comprehensive case management, and automated risk evaluation without complicated integrations.
- Fund That Flip — Fund That Flip offers customized lending for real estate investors. Partner with America's fastest-growing direct lender. Better than your hard money lender.
- Scrut Automation — Scrut Automation makes ISO 27001, SOC 2, GDPR and PCI DSS compliance easy, with 70% less Manual effort
ROX Health is a digital healthcare innovation studio empowering early-stage health startups in oncology, neurology, cardiovascular metabolism, and women's health. We provide expertise, networks, and market access.
Show more...Investment focus
- Industry: Health Care, Health Diagnostics, Apps
- Stage:Pre-Seed, Seed
- Geography: Germany, Austria
Investor stats
- Total investments: 3
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- XUND — Answer the most important health questions with AI-powered technology from XUND. Medically certified and CE marked.
- Halitus — Laser Technology x Gas Dynamics Analysis x Machine Learning.
- MindAhead — Digital Health, Med Tech, Brain Health
Investment Company
Show more...Investment focus
- Industry: Medical, Analytics, Health Diagnostics
- Stage:Series A
- Geography: Austria
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that helps people understand their health by explaining their medical reports and health data to them in a personalized, easy-to-understand, and visual way.Through its consumer apps and enterprise software, Medicus is focused on bringing meaning to data, by helping patients and users understand theirhealth, and augmenting the roles of doctors, midwives, and other healthcare providers through innovative data visualization, patient communication, and remote monitoring tools.
gcp gamma capital partners is an independent Venture Capital investment firm, focused on financing dynamic technology companies in Austria, Germany, Switzerland and CEE countries.They seek to achieve superior returns by finding assets with substantial potential in their regional and sectoral focus areas, before they appear on the radar screenof mainstream players in terms of stage and/or initial investment size.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Series A, Seed
- Geography: Austria, United States, Germany
Investor stats
- Total investments: 29
- Round size: Seed $406k–$636k; Series A $1.3M–$8M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Icomasoft — Icomasoft ag is a Swiss pioneer of agent-less software solutions providing unprecedented transparency across your virtual and physical IT infrastructure in heterogeneous datacenters.IcomasoftÂ:registered: software solutions collect essential information for mission-critical and business-critical decisions and provide simplified, automated tasksthat support administrators, IT managers and Executives to easily and confidently analyze, plan and optimize their IT capacity. icomasoftÂ:registered: software solutions are vital for your datacenter clarity.
- Henn GmbH & Co KG — Henn GmbH & Co KG develops and commercializes rapid connecting systems for hoses in automotive engine blocks.
- CNSystems Medizintechnik — CNSystems Medizintechnik sells, manufactures, and develops equipment for non-invasive, continuous monitoring of blood pressure and other essential vital parameters. The company was founded in May 1998 as a spin-off from the Medical University and University of Technology Graz, Austria.
FCPG Affi
Show more...Investment focus
- Industry: Medical, Biotechnology, Pharmaceutical
- Geography: Austria
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
Founded by two Wall Street professionals in 2002 with the goal of making companies successful by helping them raise capital and improve their management standards. This was done by taking an active role in running these companies (at the Board level and operationally) and helping to secure strategic partnerships.Over USD 100 million in assetsgenerated from successful investments in China, and more recently in Europe. All invested funds come from our partners; no 3rd party money is managed. Since the partners are investing their own capital, they are dedicated to making their investments successful.Led by Monita Mo, one of the founders and a serial entrepreneur. Our partners have decades of experience across a wide range of industries and geographical regions. All investment partners have done business in Asia and bring an extensive network of contacts for our investments. Additionally, they have started, managed, and sold businesses and understand the challenges involved.See the need to share more developed technology to other markets, especially in China, where growth opportunities may be greater. That is why we are currently focusing on companies in Europe and other developed markets that have unique technologies that can be commercialized in their home markets, Asia, and the US.
Show more...Investment focus
- Industry: Health Care, Medical Device, Software
- Stage:Series A, Seed
- Geography: Finland, Israel, Austria
Investor stats
- Total investments: 18
- Round size: Seed $1.5M–$9.3M; Series A $2.2M–$12M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Pionix — open source software as a service for charging stations / e-mobility
- piur imaging — PIUR´s tomographic ultrasound solutions turn any standard ultrasound system into a tomographic 3D imaging device, bridging the gap between 2D ultrasound and regular tomographic imaging modalities. With any conventional 2D ultrasound transducer, high-resolution tomographic images can be generated and stored as quantifiable volumes, enabling true AIpost-processing for efficient diagnostics. Current focus is on thyroid imaging where AI algorithms allow doctors a fast and objective analysis and classification of thyroid nodules.
- Nanoflex Robotics — Nanoflex Robotics develops a soft robotic system that precisely inserts specially made guidewires and catheters deep into the brain. The company provides patented magnetic navigation technology but also the necessary surgical devices. Nanoflex Robotics was established in May, 2021 in Zurich, Switzerland.
Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 104
- Round size: Seed $1.8M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — raised $250M in 2018
Portfolio highlights
- Tacalyx — Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms.
- smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
- Rinri Therapeutics — Rinri Therapeutics has been founded on pioneering research into auditory stem cells led by Professor Marcelo Rivolta at the University of Sheffield.
Medical Investor funding in Austria at a glance
Stats across 72 deals from 119 investors.
Access all 119 investors in Austria Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Investors in Austria investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 119 investors investing in Austria Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!